REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma J A J, S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Durable Goods Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Pharma J A J, S.R.O. Profile Updated: October 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharma J A J, S.R.O. is based in Czech Republic, with the head office in Chodov. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on March 18, 2009. It currently has a total number of 20 - 24 (2024) employees. From the latest financial highlights, Pharma J A J, S.R.O. reported a net sales revenue drop of 5.71% in 2024. Its’ total assets recorded a negative growth of 3.88%. The net profit margin of Pharma J A J, S.R.O. decreased by 6.36% in 2024.

Headquarters
Tovarni 1057
Chodov; Karlovarsky; Postal Code: 35735

Contact Details: Purchase the Pharma J A J, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma J A J, S.R.O. report to view the information.
Registered Capital:
Purchase the Pharma J A J, S.R.O. report to view the information.
Financial Auditors:
Purchase the Pharma J A J, S.R.O. report to view the information.
Incorporation Date:
March 18, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharma J A J, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-5.71%
Total operating revenue
-10.03%
Operating profit (EBIT)
-73.44%
EBITDA
-68.79%
Net Profit (Loss) for the Period
-75.22%
Total assets
-3.88%
Total equity
4.95%
Operating Profit Margin (ROS)
-7.92%
Net Profit Margin
-6.36%
Return on Equity (ROE)
-35.23%
Debt to Equity Ratio
-7.11%
Quick Ratio
0.14%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?